Enteral feeding is a method of delivering nutrition or medications directly in the stomach or intestine, and is usually recommended for patients suffering from chronic illnesses such as head & neck cancer, dementia and stroke. Increasing incidence of cancer and neurological diseases, growing awareness of enteral feeding and rising adoption of home and hospital enteral feeding devices would considerably drive the market growth.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/704
In 2014, neurological application was the leading segment in the enteral feeding application market mainly due to the established use of enteral feeding devices in CNS and mental health disorders. However, by 2020, cancer is expected to takeover neurological application owing to increasing adoption of enteral nutrition among cancer patients and faster rise in cancer patients.
North America held a dominant position in the enteral feeding device market in 2014, and is expected to maintain its lead throughout the forecast period. This is mainly due to high per capita spending on clinical nutrition, and well established reimbursement scenario. Europe is the second leading geography due to increasing popularity of enteral feeding among adults and pediatrics and high clinical spending in countries such as Spain, France, Germany and United Kingdom. However, the Asia-Pacific region is estimated to register the fastest growth due to growing awareness of enteral nutrition and increasing disposable income in countries like China and India.
The key companies profiled in this report include, Medtronic plc, Fresenius SE & Co. KGaA, Halyard Health, Inc., Boston Scientific Corporation, Danone, Nestl S.A., Moog, Inc., B. Braun Melsungen AG, C. R. Bard, Inc. and CONMED Corporation.
𝗚𝗲𝘁 𝗗𝗲𝘁𝗮𝗶𝗹𝗲𝗱 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/enteral-feeding-devices-market